Cytotherapy publication 2026

June 16, 2026

The first peer-reviewed EASYGEN consortium perspective examines the barriers limiting CAR-T access in Europe and the potential role of decentralised manufacturing.

The first peer-reviewed EASYGEN consortium perspective examines the barriers limiting CAR-T access in Europe and the potential role of decentralised manufacturing, automation and non-viral gene engineering in addressing them.

The article is available online ahead of its September 2026 issue publication in Cytotherapy.

AriseHealth logoOE logo2020INC logoThe Paak logoEphicient logoToogether logoToogether logo
This project has received funding from the Innovative Health Initiative Joint Undertaking (JU) under grant agreement No 101194710. The JU receives support from the European Union’s Horizon Europe research and innovation programme and EFPIA. — Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.